| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-08-4596 |
| P698 | PubMed publication ID | 19336569 |
| P2093 | author name string | Yi Zhang | |
| Marcel Smid | |||
| Jan G M Klijn | |||
| Anieta M Sieuwerts | |||
| John A Foekens | |||
| John W M Martens | |||
| Yixin Wang | |||
| John Jiang | |||
| Jack X Yu | |||
| P2860 | cites work | Global variation in copy number in the human genome | Q24658083 |
| Genomic signatures to guide the use of chemotherapeutics. | Q34576027 | ||
| Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial | Q34714877 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3795-3801 | |
| P577 | publication date | 2009-03-31 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Copy number alterations that predict metastatic capability of human breast cancer | |
| P478 | volume | 69 |
| Q57134612 | Q57134612 |
| Q60035707 | A prognostic DNA signature for T1T2 node-negative breast cancer patients |
| Q40527517 | A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer |
| Q96304936 | Amplifications of stemness genes and the capacity of breast tumors for metastasis |
| Q34491930 | An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis |
| Q40364215 | Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020. |
| Q38414983 | Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17. |
| Q33770092 | Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer |
| Q90622755 | Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer |
| Q36296457 | Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study |
| Q58813303 | Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification |
| Q33958257 | Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes |
| Q36530874 | Current analysis platforms and methods for detecting copy number variation |
| Q38296577 | Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues |
| Q38734816 | Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer |
| Q35928654 | Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation |
| Q90129866 | Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer |
| Q35832016 | Genetic characterization of breast cancer and implications for clinical management |
| Q36042790 | Genomic instability measured by inter-(simple sequence repeat) PCR and high-resolution microsatellite instability are prognostic of colorectal carcinoma survival after surgical resection |
| Q33644509 | HaplotypeCN: copy number haplotype inference with Hidden Markov Model and localized haplotype clustering |
| Q51427443 | Hepatocyte nuclear factor 1 beta induces transformation and epithelial-to-mesenchymal transition. |
| Q89143446 | Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3 |
| Q26782613 | Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential |
| Q30489312 | Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers |
| Q35889655 | Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer |
| Q37939073 | Lessons from a decade of integrating cancer copy number alterations with gene expression profiles |
| Q33694015 | MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome |
| Q34257684 | Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses. |
| Q41260173 | Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis |
| Q39551687 | Network modeling of the transcriptional effects of copy number aberrations in glioblastoma |
| Q53705532 | Overproduction of Sch9 leads to its aggregation and cell elongation in Saccharomyces cerevisiae. |
| Q34988001 | Paradoxical relationship between chromosomal instability and survival outcome in cancer |
| Q45267349 | Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. |
| Q38596926 | Pharmacogenomics in the treatment of lung cancer: an update |
| Q37327531 | Precise inference of copy number alterations in tumor samples from SNP arrays |
| Q36486836 | Prediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes. |
| Q43485091 | Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer |
| Q92382438 | RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer |
| Q35422960 | Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer |
| Q22252206 | Revealing the genetic basis of multiple sclerosis: are we there yet? |
| Q55185627 | Semiparametric odds rate model for modeling short-term and long-term effects with application to a breast cancer genetic study. |
| Q47577983 | Severe ocular phenotypes in Rbp4-deficient mice in the C57BL/6 genetic background |
| Q35067525 | Stability-based comparison of class discovery methods for DNA copy number profiles |
| Q39153926 | TPD52 represents a survival factor in ERBB2-amplified breast cancer cells. |
| Q24296824 | The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells |
| Q38015064 | The challenge of gene expression profiling in heterogeneous clinical samples |
| Q33841474 | The dChip survival analysis module for microarray data. |
| Q36304094 | The role of S6K1 in ER-positive breast cancer |
| Q38079125 | Translating metastasis-related biomarkers to the clinic--progress and pitfalls |
| Q24321395 | USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers |
| Q35258016 | Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer |
Search more.